awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38650602-10821BB4-4915-4DC2-B0A8-B52890EB1C44
Q38650602-10821BB4-4915-4DC2-B0A8-B52890EB1C44
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38650602-10821BB4-4915-4DC2-B0A8-B52890EB1C44
Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis.
P2860
Q38650602-10821BB4-4915-4DC2-B0A8-B52890EB1C44
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38650602-10821BB4-4915-4DC2-B0A8-B52890EB1C44
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f5ae4c406e1cf6c52424558e75086a0e97308059
P2860
IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)